Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 13, 2021 | Suono Bio | $8.5M Series A | Fred Shane, Mizuho Securities Principal Investment | — |
| Jun 16, 2020 | C4 Therapeutics, Inc. | $170.0M Debt / Series B | Todd Kaloudis, Adam Stone | 3E Bioventures Capital, Adage Capital Management, Axil Capital, Bain Capital Life Sciences, Commodore Capital, HBM Healthcare Investments, Janus Henderson Investors, Lightchain Capital, Logos Capital, Nextech, RA Capital Management, RTW Investments, Sphera Funds Management, T. Rowe Price Associates, Yonjin Capital |
| Jul 23, 2019 | Frequency Therapeutics | $62.0M Series C | Joseph Edelman | Axil Capital, Cobro Ventures, Deerfield Management, Polaris Founders Capital, RTW Investments |